Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APATINIB: 155 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
155
Total FAERS Reports
25 (16.1%)
Deaths Reported
42
Hospitalizations
155
As Primary/Secondary Suspect
13
Life-Threatening
1
Disabilities

First Report: 2015 · Latest Report: 20240604

What Are the Most Common APATINIB Side Effects?

#1 Most Reported
Myelosuppression
30 reports (19.4%)
#2 Most Reported
Palmar-plantar erythrodysaesthesia syndrome
28 reports (18.1%)
#3 Most Reported
Proteinuria
23 reports (14.8%)

All APATINIB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 30 19.4% 2 9
Palmar-plantar erythrodysaesthesia syndrome 28 18.1% 5 1
Proteinuria 23 14.8% 3 0
Fatigue 22 14.2% 4 1
Rash 21 13.6% 3 2
Hypertension 20 12.9% 3 1
Anaemia 19 12.3% 5 0
Diarrhoea 17 11.0% 2 2
Decreased appetite 15 9.7% 4 1
Leukopenia 15 9.7% 1 0
Disease progression 14 9.0% 4 0
Nausea 13 8.4% 3 1
Thrombocytopenia 13 8.4% 2 1
Platelet count decreased 12 7.7% 1 4
Pyrexia 11 7.1% 1 1
Hepatic function abnormal 10 6.5% 2 2
Bone marrow failure 9 5.8% 0 1
Gastrointestinal haemorrhage 9 5.8% 1 1
Hypothyroidism 9 5.8% 2 0
Vomiting 9 5.8% 3 1

Who Reports APATINIB Side Effects? Age & Gender Data

Gender: 52.9% female, 47.1% male. Average age: 54.1 years. Most reports from: CN. View detailed demographics →

Is APATINIB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 4 2 0
2016 7 1 3
2017 3 1 1
2018 2 0 0
2019 2 1 1
2020 6 3 3
2021 12 0 7
2022 15 1 13
2023 14 2 10
2024 6 0 3

View full timeline →

What Is APATINIB Used For?

IndicationReports
Hepatic cancer 18
Gastric cancer 12
Non-small cell lung cancer 11
Breast cancer 7
Hepatocellular carcinoma 6
Adenocarcinoma gastric 5
Breast cancer metastatic 5
Metastases to central nervous system 5
Serous cystadenocarcinoma ovary 5

APATINIB vs Alternatives: Which Is Safer?

APATINIB vs APIDRA APATINIB vs APIDRA SOLOSTAR APATINIB vs APIXABAN APATINIB vs APOMORPHINE APATINIB vs APRACLONIDINE APATINIB vs APREMILAST APATINIB vs APREPITANT APATINIB vs APROTININ APATINIB vs ARANESP APATINIB vs ARAVA

Official FDA Label for APATINIB

Official prescribing information from the FDA-approved drug label.